Samsung Bioepis Signs Industry-Academia Cooperation Agreement with Yonsei University for 'Bio Talent Development'

[Asia Economy Reporter Seo So-jung] Samsung Bioepis (CEO Go Han-seung) announced on the 22nd that it held an industry-academia cooperation agreement ceremony with Yonsei University (President Suh Seung-hwan) on the 21st at Yonsei University's Sinchon campus to foster outstanding talent in the bio industry.

Through this agreement, Samsung Bioepis will establish comprehensive industry-academia cooperation with Yonsei University, including academic exchanges, hold a research notebook competition, and conduct field-oriented education through the operation of the College of Life Science and Bio Pharmaceutical program courses.

Samsung Bioepis plans to educate Yonsei University undergraduate and graduate students on how to write research notebooks and award scholarships to outstanding students, as well as provide education on the global-level bio pharmaceutical development process possessed by the company.

Samsung Bioepis is actively promoting industry-academia cooperation activities to contribute to fostering outstanding talent in the bio industry and has signed industry-academia cooperation agreements with six universities nationwide (KAIST, Chonnam National University, Pohang University of Science and Technology, Sungkyunkwan University, Seoul National University, Yonsei University) since 2015.

Jung-wook Cho, Senior Executive Director of Samsung Bioepis HR Team, said, "We plan to continuously strive to nurture talent who will lead the future bio industry by actively expanding industry-academia cooperation activities with domestic universities."

Established in February 2012 and now in its 10th year, Samsung Bioepis is a bio pharmaceutical company pursuing the development and sales of biosimilars (bio pharmaceutical generics).

This content was produced with the assistance of AI translation services.